Mineralys Therapeutics, Inc. (MLYS)

CIK 1933414 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Mineralys Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 20268-K0001933414-26-000142
Nov 4, 202610-Q0001933414-26-000144
Oct 29, 20268-K0001933414-26-000136
Oct 20, 202640001508596-26-000004
Oct 20, 202640001612528-26-000002
Oct 20, 202630001612528-26-000001
Oct 20, 202630001508596-26-000003
Oct 19, 20268-K0001933414-26-000125
Oct 13, 20261440001964306-26-000466
Oct 2, 202640001933414-26-000121
Sep 30, 20261440001964306-26-000459
Sep 24, 202640001963901-26-000003
Sep 22, 20261440001950047-26-009734
Sep 22, 202640001916048-26-000014
Sep 21, 20261440001964306-26-000453
Sep 17, 20261440001964306-26-000448
Sep 17, 202640001816952-26-000005
Sep 15, 20261440001964306-26-000445
Sep 14, 20261440001964306-26-000440
Sep 9, 20261440001964306-26-000434
Aug 25, 202640001916048-26-000012
Aug 21, 20261440001964306-26-000406
Aug 17, 20261440001964306-26-000390
Aug 13, 20261440001964306-26-000385
Aug 12, 202640001933414-26-000118